Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry

The global biosimilars market is estimated to touch $15 billion by 2020. There is increased activity and growth in the biosimilars market globally with some of the best-selling biologics going off-patent.
To meet its global aspirations as a vital supplier of biosimilars, India must address some of the fundamental concerns that investors have about the Indian legal and regulatory framework for biopharmaceuticals.


Corporate Law Group


As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I agree” below, the user acknowledges the following:

there has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from us or any of our members to solicit any work through this website; 

The user wishes to gain more information about us for his/her own information and use;
the information about us is provided to the user only on his/her specific request and any information obtained or materials downloaded from this website is completely at the user’s volition and any transmission. The information provided under this website is solely available at your request for informational purposes only, should not be interpreted as soliciting or advertisement.